Digital twins—virtual doubles of things in the real world—was an idea born in 2002 as a way of looking at the lifespan of products, like space rockets and jet engines, enabling repairs remotely and helping to predict ...
Jun 8, 2022
0
14
Hyperpolarized nuclear magnetic resonance enables major medical advances in molecular diagnostics, for example for cardiovascular diseases or cancer therapy. Within the framework of the EU collaborative project "MetaboliQs," ...
May 17, 2022
0
5
A new clinical trial at the University of Cincinnati is studying the effectiveness of a new two-pronged immunotherapy treatment procedure to treat the most aggressive and deadly type of brain tumors, called glioblastomas. ...
Mar 24, 2022
0
5
Focal cortical dysplasia is a malformation of the cerebral cortex associated with one of the most severe types of epilepsy. Treatment is difficult owing to a lack of effective drugs or access to surgery. A new human model ...
Mar 23, 2022
0
6
Ludwig Maximilian University of Munich scientists have investigated how most people's immune defenses are able to curb the coronavirus so effectively that pneumonia does not occur.
Mar 9, 2022
0
82
A study reported in December in an article in European Child & Adolescent Psychiatry shows an association between child poverty and a heightened propensity to develop externalizing disorders during adolescence and early ...
Feb 9, 2022
0
3
Many pragmatic trials, which test the effects of medical treatments in everyday conditions, fail to collect data reported directly by patients (such as patient experience, burden of disease, or quality of life), or involve ...
Feb 8, 2022
0
30
Omicron emerged as a variant of concern only in November 2021, but all the mutations it contains except one had been described before that.
Feb 8, 2022
0
11
Twenty years ago, the Canadian province of Ontario launched an aggressive campaign to tackle stroke from every angle: It hyped prevention and awareness; beefed up its acute care practices and response times; and increased ...
Dec 22, 2021
0
9
The first Australian COVID-19 mRNA vaccine candidate, developed by the Monash Institute of Pharmaceutical Sciences (MIPS), has moved a step closer with production reaching a significant development milestone.
Nov 30, 2021
0
2
